TOKYO -- COVID-19 vaccine manufacturers will have produced a total of more than 12 billion doses by the end of 2021, enough to cover the portion of the world's population needed for herd immunity, a report shows.
But rich countries are on track to surpass 1 billion excess doses in their stockpiles by year-end, while access to vaccines remains limited in developing nations, even as output is accelerating.
